Journal of enzyme inhibition and medicinal chemistry
Statement of Retraction: Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.
Published: 202510.1080/14756366.2025.2591016
No abstract available for this study.